Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Paul Moynagh"'
Autor:
Xenia Kodji, Zizheng Kee, Robyn McKenna, Joao de Sousa Valente, Harriet Ravenscroft, Hayley McMillan, John Gamble, Yvonne Dombrowski, Paul Moynagh, David Brough, Fionnuala T. Lundy, Susan D. Brain, Ikhlas A. El Karim
Publikováno v:
Pharmaceuticals, Vol 14, Iss 11, p 1073 (2021)
This study investigates the role of transient receptor potential ankyrin 1 (TRPA1) in murine temporomandibular joint (TMJ) inflammatory hyperalgesia and the influence of the NLR family pyrin domain-containing 3 (NLRP3) inflammasome. Two distinct muri
Externí odkaz:
https://doaj.org/article/26fbdb45b27d4d6c906fb94d82b206c3
Autor:
Shuo Yang, Bingwei Wang, Paul Moynagh, Shuang Wen, Lu Liu, Chunyan Wu, Chanyuan Ma, Yongbing Yang, Yingchao Hu, Chunmei Ma, Yuying Jiang
Publikováno v:
Jiang, Y, Ma, C, Hu, Y, Yang, Y, Ma, C, Wu, C, Liu, L, Wen, S, Moynagh, P N, Wang, B & Yang, S 2023, ' ECSIT Is a critical factor for controlling intestinal homeostasis and tumorigenesis through regulating the translation of YAP protein ', Advanced Science . https://doi.org/10.1002/advs.202205180
The intestinal epithelium is the fastest renewing tissue in mammals and its regenerative process must be tightly controlled to minimize the risk of dysfunction and tumorigenesis. The orderly expression and activation of the YAP protein is a key step
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c07bf94af40512cb59a1e2183700440
https://doi.org/10.21203/rs.3.rs-1420724/v3
https://doi.org/10.21203/rs.3.rs-1420724/v3
Autor:
Shuo Yang, Bingwei Wang, Paul Moynagh, Shuang Wen, Lu Liu, Chunyan Wu, Min Chen, Chanyuan Ma, Yongbing Yang, Yingchao Hu, Chunmei Ma, Yuying Jiang
The intestinal epithelium is the fastest renewing tissue in mammals and has extensive flexibility to adapt to different types of damage. The orderly expression and activation of the YAP protein is the initial step in driving intestinal development an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81f0572046baac90cbadd42f28f3d7cf
https://doi.org/10.21203/rs.3.rs-1420724/v1
https://doi.org/10.21203/rs.3.rs-1420724/v1
Autor:
Jamie Z, Roberts, Caitriona, Holohan, Tamas, Sessler, Jennifer, Fox, Nyree, Crawford, Joel S, Riley, Hajrah, Khawaja, Joanna, Majkut, Emma, Evergren, Luke M, Humphreys, Jennifer, Ferris, Catherine, Higgins, Margarita, Espona-Fiedler, Paul, Moynagh, Simon S, McDade, Daniel B, Longley
Publikováno v:
Cell Death and Differentiation
TRAIL-R2 (DR5) is a clinically-relevant therapeutic target and a key target for immune effector cells. Herein, we identify a novel interaction between TRAIL-R2 and the Skp1-Cullin-1-F-box (SCF) Cullin-Ring E3 Ubiquitin Ligase complex containing Skp2